PT3010535T - Péptidos de toxoide derivados de modulina solúvel em fenol, delta toxina, superantigénios e suas fusões - Google Patents

Péptidos de toxoide derivados de modulina solúvel em fenol, delta toxina, superantigénios e suas fusões

Info

Publication number
PT3010535T
PT3010535T PT148135122T PT14813512T PT3010535T PT 3010535 T PT3010535 T PT 3010535T PT 148135122 T PT148135122 T PT 148135122T PT 14813512 T PT14813512 T PT 14813512T PT 3010535 T PT3010535 T PT 3010535T
Authority
PT
Portugal
Prior art keywords
superantigens
fusions
peptides derived
soluble modulin
delta toxin
Prior art date
Application number
PT148135122T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Integrated Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52105236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3010535(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Integrated Biotherapeutics Inc filed Critical Integrated Biotherapeutics Inc
Publication of PT3010535T publication Critical patent/PT3010535T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/085Staphylococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT148135122T 2013-06-19 2014-06-18 Péptidos de toxoide derivados de modulina solúvel em fenol, delta toxina, superantigénios e suas fusões PT3010535T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361836959P 2013-06-19 2013-06-19

Publications (1)

Publication Number Publication Date
PT3010535T true PT3010535T (pt) 2020-07-03

Family

ID=52105236

Family Applications (1)

Application Number Title Priority Date Filing Date
PT148135122T PT3010535T (pt) 2013-06-19 2014-06-18 Péptidos de toxoide derivados de modulina solúvel em fenol, delta toxina, superantigénios e suas fusões

Country Status (7)

Country Link
US (2) US9815872B2 (enExample)
EP (1) EP3010535B1 (enExample)
JP (1) JP6632974B2 (enExample)
CA (1) CA2916231C (enExample)
DK (1) DK3010535T3 (enExample)
PT (1) PT3010535T (enExample)
WO (1) WO2014205111A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014205111A1 (en) 2013-06-19 2014-12-24 Integrated Biotherapeutics, Inc. Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof
US10717766B2 (en) 2016-08-22 2020-07-21 Technion Research & Development Foundation Limited Antimicrobial peptides and uses thereof
EP3532618A4 (en) * 2016-10-27 2020-05-20 MedImmune, LLC SIGNAL POLYPEPTIDES FOR IMPROVED PROTEIN SECRETION
CN107224575B (zh) * 2017-03-06 2018-11-09 浙江海隆生物科技有限公司 奶牛金黄色葡萄球菌乳房炎亚单位疫苗的组合物及其制备方法和应用
US11260120B2 (en) 2017-07-27 2022-03-01 Integrated Biotherapeutic Vaccines, Inc. Immunogenic composition comprising a fusion peptide derived from superantigen toxoids
EP4081534B1 (en) 2020-12-18 2023-06-28 Biomedizinische Forschung & Bio-Produkte AG Protective staphylococcal exotoxin vaccine
US12370235B2 (en) 2021-03-04 2025-07-29 University Of Saskatchewan Synthetic, non-natural antimicrobial peptides inspired by Staphylococcus auricularis delta toxin
GR1010289B (el) * 2021-04-27 2022-08-29 Integrated Biotherapeutic Vaccines, Inc., Τοξοειδη πεπτιδια που προερχονται απο διαλυτη σε φαινολη μοδουλινη, τοξινη δελτα, υπεραντιγονα και συντηξεις αυτων
CN113234125B (zh) * 2021-05-10 2022-12-06 华东理工大学 自组装多肽、多肽水凝胶及其制备方法和用途
WO2023227563A1 (en) 2022-05-23 2023-11-30 Biomedizinische Forschung & Bio-Produkte AG Protective staphylococcal exotoxin vaccine
WO2023247747A1 (en) 2022-06-23 2023-12-28 Biomedizinische Forschung & Bio-Produkte AG Protective staphylococcal exotoxin vaccine

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US6593114B1 (en) * 1996-01-05 2003-07-15 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
TW517061B (en) 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6713284B2 (en) 1997-06-25 2004-03-30 The United States Of America As Represented By The Secretary Of The Army Bacterial superantigen vaccines
US7087235B2 (en) 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
DE69940157D1 (en) * 1998-07-10 2009-02-05 U S Medical Res Inst Of Infect Anthrax-impfstoff
GB0118155D0 (en) * 2001-07-25 2001-09-19 Lorantis Ltd Superantigen
WO2004080490A2 (en) * 2003-03-07 2004-09-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
US20050008633A1 (en) 2003-05-19 2005-01-13 Advanced Inhalation Research Inc. Chemical and physical modulators of bioavailability of inhaled compositions
US7754225B2 (en) 2006-07-20 2010-07-13 Glaxosmithkline Biologicals S.A. Method of protecting against staphylococcal infection
EP2178904B1 (en) * 2007-06-06 2016-11-02 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Psm peptides as vaccine targets against methicillin-resistant staphylococcus aureus
JP5658564B2 (ja) * 2007-08-31 2015-01-28 ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
CA2825770A1 (en) 2011-02-08 2012-08-16 Integrated Biotherapeutics, Inc. Immunogenic composition comprising alpha-hemolysin oligopeptides
CA2830415A1 (en) * 2011-03-16 2012-12-13 Regents Of The University Of Minnesota Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus
LT2785368T (lt) 2011-12-02 2019-06-10 Integrated Biotherapeutics, Inc. Imunogeninė kompozicija, apimanti polipeptidus, kilusius iš pantono-valentino leukocidino (pvl)
WO2014205111A1 (en) 2013-06-19 2014-12-24 Integrated Biotherapeutics, Inc. Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof

Also Published As

Publication number Publication date
EP3010535A1 (en) 2016-04-27
CA2916231C (en) 2024-02-06
DK3010535T3 (da) 2020-11-30
WO2014205111A1 (en) 2014-12-24
CA2916231A1 (en) 2014-12-24
US10174085B2 (en) 2019-01-08
US20180148482A1 (en) 2018-05-31
JP2016522259A (ja) 2016-07-28
JP6632974B2 (ja) 2020-01-22
US9815872B2 (en) 2017-11-14
US20160185829A1 (en) 2016-06-30
EP3010535A4 (en) 2017-03-01
EP3010535B1 (en) 2019-08-14

Similar Documents

Publication Publication Date Title
EP3010535A4 (en) Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof
ZA201801801B (en) A drawer, and a drawer sliding system for such drawer
EP3298804A4 (en) Identification, location, and authentication systems and methods
IL245469A0 (en) Methods and system for solvent-free processing
IL240055A0 (en) Methods, systems and software for identifying biomolecules with interaction components
IL240443A0 (en) Antibodies against tnf-a with a high level of galactosylation and their uses
ZA201503467B (en) M. tuberculosis vaccines
EP2968760A4 (en) Drug cassette, autoinjector, and autoinjector system
EP2968775A4 (en) Drug cassette, autoinjector, and autoinjector system
GB201313527D0 (en) A valve which depressurises, and a valve system
SG11201604660VA (en) Drug delivery system.
EP2972257A4 (en) Improved techniques, systems and machine readable programs for magnetic resonance
HUE048573T2 (hu) Chlamydia SP. elleni vakcinák
EP3394718A4 (en) SYSTEMS AND METHOD FOR REGISTERING CARD AUTHENTICATION READINGS
GB201614162D0 (en) Antibodies, uses thereof and conjugates thereof
EP3110484A4 (en) Powder inhaler, system and methods
IL237852A0 (en) Antibodies against amphigoline, medical preparations containing them and their use
EP2955977B8 (en) Induction heating coil, and induction heating system using same
IL257434A (en) Mrka polypeptides, antibodies, and uses thereof
IL267555B (en) Australolysin, a functionally related variant thereof, an extract containing Australolysin and uses thereof
SG11201605322RA (en) Position information authentication system, positioning terminal, and position information acquisition apparatus
SG10201913659SA (en) Foxm1-derived peptide, and vaccine including same
EP3228839A4 (en) Common rail assembly, urea injection system and application thereof
SG11201507578PA (en) Toxoid, compositions and related methods
SI2945890T1 (sl) Sistem s kolobarjem in transportno napravo za kolobar